1[1]Philip Th, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma[J]. N Engl J Med, 1995,333(23):1540～1546
2[2]Zittoun RA, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia [J]. N Engl J Med, 1995,332(3):217～224
3[3]Attal M, Harousseau JL, Stoppa AM, et al. A prospective,randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J]. N Engl J Med,1996,335(1):91～97
4[4]Avigan D, Wu Z, Joyce R, et al. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer [J]. Bone Marrow Transplant, 2000,26(2):169～177
5[5]Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogenetic marrow transplantation compared with blood stem cell transplantation[J]. Blood, 2001,97(11):3380～3385
6[6]Raaphorst FM. Bone marrow transplantation, Fetal B-cell repertoire development, and the mechanism of immune reconstitution[J]. Blood, 1998,92(12):4873～4881
7[7]Antin JH. Long term care after hematopoieti-cell transplantation in adults[J]. N Engl J Med, 2002,347(1):36～47
8[8]Storek J, Joseph A, Espino G, et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation[J]. Blood, 2001,98(13):3505～3515
9[9]Bomberger C, Jairam MS, Rodey G, et al. Lymphoid reconstitution after autologous PBSC transplantation with FACSsorted CD34+ hematopoietic progenitors[J]. Blood, 1998,91(7):2588～2600
10[10]Cérard Socie. Long-term immune reconstitution after marrow transplantation[J]. Blood, 2001,98(13):3503～3511
